PDF(Sci-hub)
Abstract：
At the cutting edge of research in biotechnology is the production of special genetically engineered organisms for use in an open, agricultural environment. We argue that the standard approaches to risk assessment and management employed by regulatory agencies are inadequate to the task of properly assessing the advisability of such experiments, as well as the even more significant prospect of widespread commercial use of genetically engineered organisms in agriculture. Given the current lack of sufficient information with which to make competent assessments of the risks involved and the attempts to gain such information in a timely fashion, we conclude that a compelling case for deliberate release programs has not been made.
摘要：
生物技术研究的前沿是生产特殊的基因工程生物，农业环境。我们认为，监管机构采用的风险评估和管理的标准方法不足以正确评估此类实验的可取性，以及基因工程生物在农业中广泛商业使用的更重要前景。鉴于当前缺乏足够的信息来对所涉及的风险进行有能力的评估，并且试图及时获得此类信息，我们得出的结论是，没有提出令人信服的故意发布计划的理由。
